SERECOR 300 mg, extended-release capsule 60 capsules
Active ingredients: Hydroquinidine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule60 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SERECOR 300 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 60 gélule(s)
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Aug 1981
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60518136CIP73240087CIP133400932400874Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROQUINIDINE (CHLORHYDRATE D')gélule | 300 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.